| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8K | -99.8% |
| R&D Expense | $9.2M | -79.2% |
| SG&A Expense | $6.6M | -54.5% |
| Operating Income | -$41.0M | +25.8% |
| Pre-tax Income | -$23.4M | +59.2% |
| Income Tax | $5K | -64.3% |
| Net Income | -$23.4M | +59.2% |
| EPS (Basic) | -$1.92 | +78.2% |
| EPS (Diluted) | -$1.92 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.9M | -21.3% |
| Current Assets | $19.8M | -60.4% |
| Total Assets | $19.8M | -73.8% |
| Current Liabilities | $7.1M | -65.3% |
| Stockholders' Equity | $12.8M | -70.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.7M | +38.7% |
| Capital Expenditures | $14K | -93.5% |
| Investing Cash Flow | $25.3M | -34.6% |
| Financing Cash Flow | $172K | -99.2% |
| Free Cash Flow | -$31.7M | +38.9% |
| +78.2% |